Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Mar 15, 2008 (Vol. 28, No. 6)

Office of Research Integrity

URL:www.ori.dhhs.gov
  • Easy access to important info
  • None
Related to the subject of plagiarism (and, in a sense, a broader aspect of it) is that of Research Integrity. Helping to guide researchers in this matter is the Office of Research Integrity, hosted by the Department of Health and Human Sciences. Like the Plagiarism.org site above, the Office of Research Integrity is a one place to visit to see all that concerns ethics of research in federal grants from the U.S. Public Health Service. At the site, visitors will find a wealth of news articles, discussions, conference info, ways of dealing with misconduct, an extensive list of policy information, newsletters, handbooks, annual reports, and educational materials on the Responsible Conducting of Research. If you’re looking to learn more about ethical considerations of scientific research, the Office of Research Integrity’s site is an outstanding government resource to consult.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »